Navigation Links
IU researchers report first effective treatment of tumors arising from common genetic disease NF1
Date:11/1/2012

dy reported in Lancet Oncology, of 23 patients who received the drug for at least six months, six experienced a 20 percent or more decrease in the volume of one or more plexiform neurofibromas, and 30 percent of patients had improvements in symptoms.

Primary investigator D. Wade Clapp, M.D., Richard L. Schreiner Professor and chairman of the Department of Pediatrics, noted that even relatively small reductions in tumor size can result in significant relief of symptoms for patients, such as improved breathing and restoration of bladder control.

In earlier laboratory research, the researchers determined that Gleevec was effective in tissue culture and mouse models of NF1 tumors after discovering that a cellular signaling mechanism that Gleevec targets in chronic myeloid leukemia also played an important role in development of NF1 tumors. Reporting that finding in the journal Cell in 2008, the research team also reported that in a compassionate use protocol, they had treated a 3-year-old girl with a life-threatening tumor compressing her airway. The girl's tumor shrank by half within three months of treatment.

Although Gleevec has been widely used as a treatment for chronic myeloid leukemia and has been prescribed in some cases for long periods without serious side effects, 13 of the initial 36 patients enrolled in the IU study dropped out before their results could be analyzed at six months of treatment. Nine of the 13 left due to problems taking the drug or side effects. The authors noted that they used the previously established maximum tolerated dose for Gleevec for this study to ensure that any drug activity against any NF1 tumors would be observed. This approach was taken among patients who had been living with slow-growing tumors for long periods of time and therefore were less likely to accept drug side effects than patients with malignant tumors, the authors suggested. Dosages have been modified in subsequent studies.

'/>"/>
Contact: Eric Schoch
eschoch@iu.edu
317-274-7722
Indiana University
Source:Eurekalert  

Page: 1 2 3

Related medicine news :

1. OHSU researchers discover potential way to repair brain damage in multiple sclerosis
2. Penn researchers find error reporting improves perceptions of safety and may reduce incidents
3. Common Antidepressants Too Risky During Pregnancy, Researchers Say
4. Mechanism found for destruction of key allergy-inducing complexes, Stanford researchers say
5. Feinstein Institute researchers discover that bean used in Chinese food could protect against sepsis
6. Mayo Clinic researchers develop new tools to better treat ADHD patients in early stages
7. Moffitt Researchers find genetic predictors of fatigue for some prostate cancer patients
8. Penn Medicine researchers map strategy for choosing wisely on low-value health care services
9. Researchers ID potential patient population who may benefit from novel anti-platelet treatment
10. Moffitt researchers identify unique immune gene signature across thousands of patients solid tumors
11. Mount Sinai researchers identify predictors for inpatient pain
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
IU researchers report first effective treatment of tumors arising from common genetic disease NF1
(Date:8/31/2015)... ... August 31, 2015 , ... How ... and others—to hold down costs? , In a commentary for The American ... presents the concept of “clinical efficacy,” which would bind parties together in agreements ...
(Date:8/31/2015)... ... ... Three Bakers Gluten Free Bakery launched the redesign of its website, http://www.threebakers.com ... their offering of gluten-free breads and pizzas, living without gluten, and resources for celiac ... share information about our gluten free product offerings, but also to really be a ...
(Date:8/31/2015)... ... August 31, 2015 , ... Physicians’ Education Resource®, LLC ... Symposium: Innovative Cancer Therapy for Tomorrow® meeting, is seeking abstract submissions for ... York City. The annual legacy meeting uses a variety of formats to educate ...
(Date:8/31/2015)... New York (PRWEB) , ... August 31, 2015 , ... ... autumn, when play-offs and the World Series will dominate the sports world. Fans desire ... and eventually advance to the final series. For children, especially those who are too ...
(Date:8/31/2015)... ... August 31, 2015 , ... The German soccer league ... system (CMS) and make website updates quicker and more flexible. The company's CMS ... the Bundesliga (the German equivalent of the U.S. Soccer Federation) more modern, exciting ...
Breaking Medicine News(10 mins):Health News:How “Clinical Efficacy” Can Rein in Healthcare Costs 2Health News:How “Clinical Efficacy” Can Rein in Healthcare Costs 3Health News:Three Bakers Gluten Free Bakery Announces Launch of New Website 2Health News:Physicians’ Education Resource® Seeks Abstracts for the Upcoming Chemotherapy Foundation Symposium: Innovative Cancer Therapy for Tomorrow® 2Health News:Physicians’ Education Resource® Seeks Abstracts for the Upcoming Chemotherapy Foundation Symposium: Innovative Cancer Therapy for Tomorrow® 3Health News:Physicians’ Education Resource® Seeks Abstracts for the Upcoming Chemotherapy Foundation Symposium: Innovative Cancer Therapy for Tomorrow® 4Health News:New Children's Baseball Series Offers Young Fans a Way to Celebrate the World Series 2Health News:On the Ball with FirstSpirit: German Soccer League (DFL Digital Sports) Opts for e-Spirit’s CMS 2
... we issued a,recall of our peanut butter distributed to food service ... issued the recall after learning that salmonella had been discovered in,an ... it clear that,we do not manufacture King Nut peanut butter nor ... the distributors. , Since that time, we ...
... Jan. 12 Rite Aid Corporation (Rite Aid) and ... to pay $5 million in civil penalties to settle ... the Department of Justice announced today. In addition to ... its subsidiaries agreed to a compliance plan with the ...
... 12 Quest Diagnostics Incorporated (NYSE: DGX ... and services, announced today that it will report fourth-quarter ... for 2009 on Monday, January 26, before the market ... investors to discuss the results beginning at 8:30 a.m. ...
... of approval provides quality assurance to consumers and ... today that it has been awarded full accreditation ... DC-based health care accrediting organization that establishes quality ... Benefit Management accreditation provides a symbol of excellence ...
... Payment default by small biopharma client has negative impact- ... of backlog/receivables- Second quarter new business wins are strong; ... year-over-yearBOSTON, Jan. 12 PAREXEL International Corporation (Nasdaq: ... biopharma client that it will be unable to continue ...
... loss in both eyes read 29 words per minute slower ... may lead to reading problems in older adults, a new ... Wilmer Eye Institute found people with glaucoma in both eyes ... glaucoma. They also were almost twice as likely to have ...
Cached Medicine News:Health News:Rite Aid Corporation and Subsidiaries Agree to Pay $5 Million in Civil Penalties to Resolve Violations in Eight States of the Controlled Substances Act 2Health News:Rite Aid Corporation and Subsidiaries Agree to Pay $5 Million in Civil Penalties to Resolve Violations in Eight States of the Controlled Substances Act 3Health News:Rite Aid Corporation and Subsidiaries Agree to Pay $5 Million in Civil Penalties to Resolve Violations in Eight States of the Controlled Substances Act 4Health News:Quest Diagnostics to Release Fourth Quarter and Full Year 2008 Financial Results 2Health News:FutureScripts(R) Earns URAC Pharmacy Benefit Manager Accreditation 2Health News:PAREXEL Reports Preliminary Second Quarter Results 2Health News:PAREXEL Reports Preliminary Second Quarter Results 3Health News:PAREXEL Reports Preliminary Second Quarter Results 4Health News:PAREXEL Reports Preliminary Second Quarter Results 5Health News:PAREXEL Reports Preliminary Second Quarter Results 6
(Date:8/31/2015)... , Aug. 31, 2015  Daktari Diagnostics today announced ... the United States and Canada ... test. The deal, worth up to $8.5 million over the ... the clinical validation and regulatory approval of Daktari,s HCV test. ... a point-of-care instrument that can detect low levels of virus ...
(Date:8/31/2015)... , August 31, 2015 ... that the global cardiovascular monitoring and diagnostic devices ... is predicted to reach a value of approximately ... of 9.7% between 2013 and 2019. The title ... Devices Market (ECG, Holter Monitors, Event Monitors, Cardiovascular ...
(Date:8/31/2015)... SAN FRANCISCO , Aug. 31, 2015  On ... District of Oregon denied motions ... Inc. (NASDAQ: GALE ) and certain of its ... had facilitated a "pump and dump" scheme to artificially ... trading period while the stock price was inflated, sold ...
Breaking Medicine Technology:Daktari Enters Collaboration Agreement with Merck to Develop Test for Hepatitis C Virus 2Daktari Enters Collaboration Agreement with Merck to Develop Test for Hepatitis C Virus 3Cardiovascular Monitoring and Diagnostic Devices Market to Reach US$7.0 Billion in 2019 Owing to Global Rise in Diabetes and Obesity: Transparency Market Research 2Cardiovascular Monitoring and Diagnostic Devices Market to Reach US$7.0 Billion in 2019 Owing to Global Rise in Diabetes and Obesity: Transparency Market Research 3Cardiovascular Monitoring and Diagnostic Devices Market to Reach US$7.0 Billion in 2019 Owing to Global Rise in Diabetes and Obesity: Transparency Market Research 4Cardiovascular Monitoring and Diagnostic Devices Market to Reach US$7.0 Billion in 2019 Owing to Global Rise in Diabetes and Obesity: Transparency Market Research 5Galena Biopharma, Inc. Stock Alert: Schubert Firm Investigates Potential Breaches of Fiduciary Duty 2
... CARE Double Swivel Elbow is designed ... provide flexibility without connectors. Features one ... for better feel. Numbered catheter allows ... catheter advance. Offers multiple tracheostomy sizes, ...
... soft, flexible whistle tip suction catheter ... that includes: One pair of vinyl ... ml bottle of sterile saline. Components ... with cuffed gloves and catheter inside ...
... suction catheters are available ... , ,All Portex® ... are latex-free., ,Maxi-Flo® ... catheter tip design which ...
... Maxi-Flo® suction catheter included with each kit ... ,All Portex® No Pour Pak® II ... ,No Pour Pak® II suction catheter ... infections, protecting the patient and clinician from ...
Medicine Products: